©The Author(s) 2016.
World J Gastrointest Oncol. Apr 15, 2016; 8(4): 410-415
Published online Apr 15, 2016. doi: 10.4251/wjgo.v8.i4.410
Published online Apr 15, 2016. doi: 10.4251/wjgo.v8.i4.410
Table 3 Influence of T category, and N category on the 5-year survival rate of patients with middle third gastric carcinoma surgically treated with curative intent
| Variables | PGC (n = 254) (%) | MGC (n = 764) (%) | P value |
| Depth of invasion | |||
| T1 | 77.6 | 88.8 | 0.0477 |
| T2 | 76.0 | 76.1 | 0.7534 |
| T3 | 44.6 | 45.1 | 0.9900 |
| T4 | 17.3 | 16.8 | 0.1698 |
| Lymph node metastasis | |||
| N0 | 72.3 | 79.9 | 0.0270 |
| N1 | 42.7 | 49.6 | 0.6285 |
| N2 | 33.4 | 31.0 | 0.6933 |
| Stage | |||
| I | 77.2 | 87.9 | 0.0420 |
| II | 68.4 | 63.2 | 0.5566 |
| III | 33.7 | 36.3 | 0.5823 |
| IV | 17.6 | 21.8 | 0.3635 |
- Citation: Kim JH, Joo JK, Ryu SY, Kim HG, Lee JH, Kim DY. Clinicopathological features of patients with middle third gastric carcinoma. World J Gastrointest Oncol 2016; 8(4): 410-415
- URL: https://www.wjgnet.com/1948-5204/full/v8/i4/410.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v8.i4.410